Literature DB >> 23119123

The Synthesis and Antimicrobial Activity of Heterocyclic Derivatives of Totarol.

Michelle B Kim1, Terrence E O'Brien, Jared T Moore, David E Anderson, Marie H Foss, Doug-Las B Weibel, James B Ames, Jared T Shaw.   

Abstract

The synthesis and antimicrobial activity heterocyclic analogs of the diterpenoid totarol are described. An advanced synthetic intermediate with a n class="Chemical">ketone on the A-ring is used to attach fused heterocycles and a carbon-to-nitrogen atom replacement is made on the B-ring by de novo synthesis. A-ring analogs with an indole attached exhibit, for the first time, enhanced antimicrobial activity relative to the parent natural product. Preliminary experiments demonstrate that the indole analogs do not target the bacterial cell division protein FtsZ as had been hypothesized for totarol.

Entities:  

Year:  2012        PMID: 23119123      PMCID: PMC3483140          DOI: 10.1021/ml3001775

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  26 in total

1.  A detergent-based assay for the detection of promiscuous inhibitors.

Authors:  Brian Y Feng; Brian K Shoichet
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

2.  Stoichiometry and physical chemistry of promiscuous aggregate-based inhibitors.

Authors:  Kristin E D Coan; Brian K Shoichet
Journal:  J Am Chem Soc       Date:  2008-06-28       Impact factor: 15.419

3.  Synthetic access to bent polycycles by cation-pi cyclization.

Authors:  Ryan A Shenvi; E J Corey
Journal:  Org Lett       Date:  2010-08-06       Impact factor: 6.005

4.  Restoring methicillin-resistant Staphylococcus aureus susceptibility to β-lactam antibiotics.

Authors:  Christopher M Tan; Alex G Therien; Jun Lu; Sang H Lee; Alexandre Caron; Charles J Gill; Christian Lebeau-Jacob; Liliana Benton-Perdomo; João M Monteiro; Pedro M Pereira; Nathaniel L Elsen; Jin Wu; Kathleen Deschamps; Mihai Petcu; Simon Wong; Etienne Daigneault; Susanne Kramer; Lianzhu Liang; Eugene Maxwell; David Claveau; John Vaillancourt; Kathryn Skorey; John Tam; Hao Wang; Timothy C Meredith; Susan Sillaots; Lisa Wang-Jarantow; Yeeman Ramtohul; Eric Langlois; France Landry; John C Reid; Gopal Parthasarathy; Sujata Sharma; Anastasia Baryshnikova; Kevin J Lumb; Mariana G Pinho; Stephen M Soisson; Terry Roemer
Journal:  Sci Transl Med       Date:  2012-03-21       Impact factor: 17.956

5.  The synthesis and antibacterial activity of totarol derivatives. Part 1: modifications of ring-C and pro-drugs.

Authors:  G B Evans; R H Furneaux; M B Gravestock; G P Lynch; G K Scott
Journal:  Bioorg Med Chem       Date:  1999-09       Impact factor: 3.641

6.  Synthesis and antitumor activity of cholest-4 alpha-methyl-7-en-3beta-ol derivatives.

Authors:  Lan He; Yumei Liu; Jiangong Shi; Qiang Pei
Journal:  Steroids       Date:  2006-02-28       Impact factor: 2.668

7.  The synthesis and antibacterial activity of totarol derivatives. Part 3: Modification of ring-B.

Authors:  G B Evans; R H Furneaux; G J Gainsford; M P Murphy
Journal:  Bioorg Med Chem       Date:  2000-07       Impact factor: 3.641

8.  Synthesis and evaluation of a novel series of heterocyclic oleanolic acid derivatives with anti-osteoclast formation activity.

Authors:  Jun-Feng Li; Yu Zhao; Min-Min Cai; Xiao-Fei Li; Jian-Xin Li
Journal:  Eur J Med Chem       Date:  2008-12-31       Impact factor: 6.514

9.  Antibacterial activity of anacardic acid and totarol, alone and in combination with methicillin, against methicillin-resistant Staphylococcus aureus.

Authors:  H Muroi; I Kubo
Journal:  J Appl Bacteriol       Date:  1996-04

10.  A synthesis of the carbon skeleton of maoecrystal V.

Authors:  Paul J Krawczuk; Niklas Schöne; Phil S Baran
Journal:  Org Lett       Date:  2009-11-05       Impact factor: 6.005

View more
  2 in total

Review 1.  The Current Status of the Pharmaceutical Potential of Juniperus L. Metabolites.

Authors:  Wilson R Tavares; Ana M L Seca
Journal:  Medicines (Basel)       Date:  2018-07-31

2.  Synthesis, Type II diabetes inhibitory activity, antimicrobial evaluation and docking studies of indeno[1,2-c]pyrazol-4(1H)-ones.

Authors:  Satbir Mor; Suchita Sindhu
Journal:  Med Chem Res       Date:  2019-10-26       Impact factor: 1.965

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.